Insmed Inc (NASDAQ: INSM) kicked off on Monday, down -3.99% from the previous trading day, before settling in for the closing price of $73.62. Over the past 52 weeks, INSM has traded in a range of $55.74-$84.91.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 21.66%. While this was happening, its average annual earnings per share was recorded 6.01%. With a float of $177.29 million, this company’s outstanding shares have now reached $181.90 million.
Let’s determine the extent of company efficiency that accounts for 1271 employees. In terms of profitability, gross margin is 76.16%, operating margin of -230.21%, and the pretax margin is -264.87%.
Insmed Inc (INSM) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Insmed Inc is 2.66%, while institutional ownership is 109.34%. The most recent insider transaction that took place on Jun 05 ’25, was worth 138,106. In this transaction Chief Legal Officer of this company sold 1,879 shares at a rate of $73.50, taking the stock ownership to the 67,718 shares. Before that another transaction happened on Jun 05 ’25, when Company’s Officer proposed sale 1,879 for $73.47, making the entire transaction worth $138,050.
Insmed Inc (INSM) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 6.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 47.10% during the next five years compared to -13.12% drop over the previous five years of trading.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Take a look at Insmed Inc’s (INSM) current performance indicators. Last quarter, stock had a quick ratio of 5.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 33.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.95, a number that is poised to hit -1.30 in the next quarter and is forecasted to reach -3.66 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Looking closely at Insmed Inc (NASDAQ: INSM), its last 5-days average volume was 2.08 million, which is a drop from its year-to-date volume of 2.16 million. As of the previous 9 days, the stock’s Stochastic %D was 72.05%. Additionally, its Average True Range was 2.63.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 41.94%, which indicates a significant decrease from 57.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.52% in the past 14 days, which was lower than the 40.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $69.77, while its 200-day Moving Average is $73.05.
